Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sara Galozzi, Katrin Marcus & Katalin Barkovits. (2015) Amyloid-β as a biomarker for Alzheimer’s disease: quantification methods in body fluids. Expert Review of Proteomics 12:4, pages 343-354.
Read now
Read now
Jean-Daniel Abraham, Sophie Calvayrac-Pawlowski, Sandra Cobo, Nicolas Salvetat, Guillaume Vicat, Laurence Molina, Jacques Touchon, Bernard-François Michel, Franck Molina, Jean-Michel Verdier, Jeannette Fareh & Chantal Mourton-Gilles. (2011) Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias. Biomarkers 16:2, pages 161-171.
Read now
Read now
Orestes Vicente Forlenza, Breno Satler Diniz, Antonio Lucio Teixeira, Elida Benquique Ojopi, Leda Leme Talib, Vanessa Amaral Mendonça, Giselle Izzo & Wagner Farid Gattaz. (2010) Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. The World Journal of Biological Psychiatry 11:6, pages 774-780.
Read now
Read now
Articles from other publishers (106)
Jessica Stark, Kelly J. Hiersche, Ju-Chi Yu, Alexander N. Hasselbach, Hervé Abdi & Scott M. Hayes. (2023) Partial Least Squares Regression Analysis of Alzheimer’s Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment. Journal of Alzheimer's Disease 93:2, pages 633-651.
Crossref
Crossref
Jiajia Fu, Xiaohui Lai, Yan Huang, Ting Bao, Jing Yang, Sihui Chen, Xueping Chen & Huifang Shang. (2023) Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease. BMC Neurology 23:1.
Crossref
Crossref
Ze-Hu Sheng, Ling-Zhi Ma, Jia-Yao Liu, Ya-Nan Ou, Bing Zhao, Ya-Hui Ma & Lan Tan. (2022) Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Richa Tyagi, Bhupesh Vaidya & Shyam Sunder Sharma. (2022) Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role. Pharmacological Reports 74:5, pages 790-817.
Crossref
Crossref
Lucas Porcello Schilling, Marcio Luiz Figueredo Balthazar, Márcia Radanovic, Orestes Vicente Forlenza, Marcela Lima Silagi, Jerusa Smid, Breno José Alencar Pires Barbosa, Norberto Anízio Ferreira Frota, Leonardo Cruz de Souza, Francisco Assis Carvalho Vale, Paulo Caramelli, Paulo Henrique Ferreira Bertolucci, Márcia Lorena Fagundes Chaves, Sonia Maria Dozzi Brucki, Benito Pereira Damasceno & Ricardo Nitrini. (2022) Diagnóstico da doença de Alzheimer: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Dementia & Neuropsychologia 16:3 suppl 1, pages 25-39.
Crossref
Crossref
Lucas Porcello Schilling, Marcio Luiz Figueredo Balthazar, Márcia Radanovic, Orestes Vicente Forlenza, Marcela Lima Silagi, Jerusa Smid, Breno José Alencar Pires Barbosa, Norberto Anízio Ferreira Frota, Leonardo Cruz de Souza, Francisco Assis Carvalho Vale, Paulo Caramelli, Paulo Henrique Ferreira Bertolucci, Márcia Lorena Fagundes Chaves, Sonia Maria Dozzi Brucki, Benito Pereira Damasceno & Ricardo Nitrini. (2022) Diagnosis of Alzheimer’s disease: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Dementia & Neuropsychologia 16:3 suppl 1, pages 25-39.
Crossref
Crossref
Jessica Stark, Daniela J. Palombo, Jasmeet P. Hayes, Kelly J. Hiersche, Alexander N. Hasselbach & Scott M. Hayes. (2021) Partial Least Squares Analysis of Alzheimer’s Disease Biomarkers, Modifiable Health Variables, and Cognition in Older Adults with Mild Cognitive Impairment. Journal of the International Neuropsychological Society 28:8, pages 781-789.
Crossref
Crossref
Sarah Holper, Rosie Watson & Nawaf Yassi. (2022) Tau as a Biomarker of Neurodegeneration. International Journal of Molecular Sciences 23:13, pages 7307.
Crossref
Crossref
Dylan Shea & Valerie Daggett. (2022) Amyloid-β Oligomers: Multiple Moving Targets. Biophysica 2:2, pages 91-110.
Crossref
Crossref
Ya-Xin Chen, Ning Liang, Xiao-Ling Li, Si-Hong Yang, Yan-Ping Wang & Nan-Nan Shi. (2021) Diagnosis and Treatment for Mild Cognitive Impairment: A Systematic Review of Clinical Practice Guidelines and Consensus Statements. Frontiers in Neurology 12.
Crossref
Crossref
Alexandra L. Clark, Alexandra J. Weigand, Kelsey R. Thomas, Seraphina K. Solders, Lisa Delano-Wood, Mark W. Bondi, Rachel A. Bernier, Erin E. Sundermann, Sarah J. Banks & Katherine J. Bangen. (2021) Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment. Journal of Alzheimer's Disease 80:4, pages 1451-1463.
Crossref
Crossref
Jessica E Owen, Bryndis Benediktsdottir, Elizabeth Cook, Isleifur Olafsson, Thorarinn Gislason & Stephen R Robinson. (2021) Alzheimer’s disease neuropathology in the hippocampus and brainstem of people with obstructive sleep apnea. Sleep 44:3.
Crossref
Crossref
Donovan A. McGrowder, Fabian Miller, Kurt Vaz, Chukwuemeka Nwokocha, Cameil Wilson-Clarke, Melisa Anderson-Cross, Jabari Brown, Lennox Anderson-Jackson, Lowen Williams, Lyndon Latore, Rory Thompson & Ruby Alexander-Lindo. (2021) Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives. Brain Sciences 11:2, pages 215.
Crossref
Crossref
Linda J.C. van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M.C. van Leijsen, Jurgen A.H.R. Claassen, Andrea Arighi, Marco Bozzali, Jorge Cannas, Enrica Cavedo, Paolo Eusebi, Lucia Farotti, Chiara Fenoglio, Juan Fortea, Giovanni B. Frisoni, Daniela Galimberti, Viviana Greco, Sanna-Kaisa Herukka, Yawu Liu, Alberto Lleó, Alexandre de Mendonça, Flavio M. Nobili, Lucilla Parnetti, Agnese Picco, Maria Pikkarainen, Nicola Salvadori, Elio Scarpini, Hilkka Soininen, Roberto Tarducci, Andrea Urbani, Eduard Vilaplana, Olga Meulenbroek, Bram Platel, Marcel M. Verbeek & H. Bea Kuiperij. (2021) White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers. Journal of Alzheimer's Disease 79:1, pages 163-175.
Crossref
Crossref
Shivani Sharma & Ashima Nehra. 2021. Research Anthology on Diagnosing and Treating Neurocognitive Disorders. Research Anthology on Diagnosing and Treating Neurocognitive Disorders
123
146
.
Habib Yaribeygi, Ali Rashidy-Pour, Stephen L. Atkin, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) GLP-1 mimetics and cognition. Life Sciences 264, pages 118645.
Crossref
Crossref
Ying Zhang, Yajing Hao, Lang Li, Kai Xia & Guorong Wu. (2020) A Novel Computational Proxy for Characterizing Cognitive Reserve in Alzheimer’s Disease. Journal of Alzheimer's Disease 78:3, pages 1217-1228.
Crossref
Crossref
Michael A. Sugarman, Henrik Zetterberg, Kaj Blennow, Yorghos Tripodis, Ann C. McKee, Thor D. Stein, Brett Martin, Joseph N. Palmisano, Eric G. Steinberg, Irene Simkin, Andrew E. Budson, Ronald Killiany, Maureen K. O'Connor, Rhoda Au, Wendy Wei Qiao Qiu, Lee E. Goldstein, Neil W. Kowall, Jesse Mez, Robert A. Stern & Michael L. Alosco. (2020) A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease. Neurobiology of Aging 94, pages 60-70.
Crossref
Crossref
Bin Wu, Haiqing Cai, Shen Tang, Yilu Xu, Qianqian Shi, Lancheng Wei, Ling Meng, Ning Zhang, Xinhang Wang, Deqiang Xiao, Yunfeng Zou, Xiaobo Yang, Xiyi Li & Cailing Lu. (2020) Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models. Neurotherapeutics 17:4, pages 1878-1896.
Crossref
Crossref
Christian Sandøe Musaeus, Malene Schjønning Nielsen, Jørgen Sandøe Musaeus & Peter Høgh. (2020) Electroencephalographic Cross-Frequency Coupling as a Sign of Disease Progression in Patients With Mild Cognitive Impairment: A Pilot Study. Frontiers in Neuroscience 14.
Crossref
Crossref
Marcos Pais, Luana Martinez, Octávio Ribeiro, Júlia Loureiro, Romel Fernandez, Leandro Valiengo, Paulo Canineu, Florindo Stella, Leda Talib, Marcia Radanovic & Orestes V. Forlenza. (2020) Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges. Brazilian Journal of Psychiatry 42:4, pages 431-441.
Crossref
Crossref
Ghazala Iqbal, Nady Braidy & Touqeer Ahmed. (2020) Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population. Frontiers in Aging Neuroscience 12.
Crossref
Crossref
Chao Song, Suya Que, Lucas Heimer & Long Que. (2020) On-Chip Detection of the Biomarkers for Neurodegenerative Diseases: Technologies and Prospects. Micromachines 11:7, pages 629.
Crossref
Crossref
P.M. Rossini, R. Di Iorio, F. Vecchio, M. Anfossi, C. Babiloni, M. Bozzali, A.C. Bruni, S.F. Cappa, J. Escudero, F.J. Fraga, P. Giannakopoulos, B. Guntekin, G. Logroscino, C. Marra, F. Miraglia, F. Panza, F. Tecchio, A. Pascual-Leone & B. Dubois. (2020) Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts. Clinical Neurophysiology 131:6, pages 1287-1310.
Crossref
Crossref
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, Thi Thuy Dung Nguyen & Van Giau Vo. (2020) Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis. Diagnostics 10:5, pages 326.
Crossref
Crossref
Hao Wu, Shuangshuang Wei, Yonglin Huang, Lintao Chen, Yuerong Wang, Xinli Wu, Zhuandan Zhang, Yechun Pei & Dayong Wang. (2020) Aβ monomer induces phosphorylation of Tau at Ser‐214 through β2AR‐PKA‐JNK signaling pathway. The FASEB Journal 34:4, pages 5092-5105.
Crossref
Crossref
Domingo Sánchez, Miguel Castilla-Marti, Marta Marquié, Sergi Valero, Sonia Moreno-Grau, Octavio Rodríguez-Gómez, Albert Piferrer, Gabriel Martínez, Joan Martínez, Itziar De Rojas, Isabel Hernández, Carla Abdelnour, Maitée Rosende-Roca, Liliana Vargas, Ana Mauleón, Silvia Gil, Montserrat Alegret, Gemma Ortega, Ana Espinosa, Alba Pérez-Cordón, Ángela Sanabria, Natalia Roberto, Andreea Ciudin, Rafael Simó, Cristina Hernández, Lluís Tárraga, Mercè Boada & Agustín Ruiz. (2020) Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic. Scientific Reports 10:1.
Crossref
Crossref
Attila A. Seyhan & Claudio Carini. (2019) Are innovation and new technologies in precision medicine paving a new era in patients centric care?. Journal of Translational Medicine 17:1.
Crossref
Crossref
Jessyka Maria de França Bram, Leda Leme Talib, Helena Passarelli Giroud Joaquim, Tamires Alves Sarno, Wagner Farid Gattaz & Orestes Vicente Forlenza. (2018) Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience 269:8, pages 963-972.
Crossref
Crossref
Franc Llorens, Anna Villar-Piqué, Niccolò Candelise, Isidre Ferrer & Inga Zerr. 2019. Cognitive Disorders. Cognitive Disorders.
Domingo Sánchez, Miguel Castilla-Marti, Octavio Rodríguez-Gómez, Sergi Valero, Albert Piferrer, Gabriel Martínez, Joan Martínez, Judit Serra, Sonia Moreno-Grau, Begoña Hernández-Olasagarre, Itziar De Rojas, Isabel Hernández, Carla Abdelnour, Maitée Rosende-Roca, Liliana Vargas, Ana Mauleón, Miguel A. Santos-Santos, Montserrat Alegret, Gemma Ortega, Ana Espinosa, Alba Pérez-Cordón, Ángela Sanabria, Andrea Ciudin, Rafael Simó, Cristina Hernández, Pablo Villoslada, Agustín Ruiz, Lluís Tàrraga & Mercè Boada. (2018) Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease. Scientific Reports 8:1.
Crossref
Crossref
Shota Suzumura, Aiko Osawa, Natsumi Maeda, Yuko Sano, Akihiko Kandori, Tomohiko Mizuguchi, Ying Yin & Izumi Kondo. (2018) Differences among patients with Alzheimer's disease, older adults with mild cognitive impairment and healthy older adults in finger dexterity. Geriatrics & Gerontology International 18:6, pages 907-914.
Crossref
Crossref
Kyle Steenland, Liping Zhao, Samantha E. John, Felicia C. Goldstein, Allan Levey & Alonso Alvaro. (2018) A ‘Framingham-like’ Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer’s Disease Using Multidomain Information. Journal of Alzheimer's Disease 63:4, pages 1383-1393.
Crossref
Crossref
Shivani Sharma & Ashima Nehra. 2018. Handbook of Research on Geriatric Health, Treatment, and Care. Handbook of Research on Geriatric Health, Treatment, and Care
94
117
.
Yaping Liu, Xiaojing He, Yanling Li & Tian Wang. (2018) Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkers. Biochemical and Biophysical Research Communications 495:1, pages 1144-1150.
Crossref
Crossref
James W. Herron, Louis Nerurkar & Jonathan Cavanagh. 2018. Biomarkers in Psychiatry. Biomarkers in Psychiatry
45
78
.
Lutz Frölich, Oliver Peters, Piotr Lewczuk, Oliver Gruber, Stefan J. Teipel, Hermann J. Gertz, Holger Jahn, Frank Jessen, Alexander Kurz, Christian Luckhaus, Michael Hüll, Johannes Pantel, Friedel M. Reischies, Johannes Schröder, Michael Wagner, Otto Rienhoff, Stefanie Wolf, Chris Bauer, Johannes Schuchhardt, Isabella Heuser, Eckart Rüther, Fritz Henn, Wolfgang Maier, Jens Wiltfang & Johannes Kornhuber. (2017) Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia. Alzheimer's Research & Therapy 9:1.
Crossref
Crossref
Naidong Weng. 2017. Targeted Biomarker Quantitation by LC–MS. Targeted Biomarker Quantitation by LC–MS
1
16
.
Lih-Fen Lue, Marwan N. Sabbagh, Ming-Jang Chiu, Naomi Jing, Noelle L. Snyder, Christopher Schmitz, Andre Guerra, Christine M. Belden, Ta-Fu Chen, Che-Chuan Yang, Shieh-Yueh Yang, Douglas G. Walker, Kewei Chen & Eric M. Reiman. (2017) Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts. Frontiers in Aging Neuroscience 9.
Crossref
Crossref
Qingmei Kang, Yue Xiang, Dan Li, Jie Liang, Xiong Zhang, Fanlin Zhou, Mengyuan Qiao, Yingling Nie, Yurong He, Jingyi Cheng, Yubing Dai & Yu Li. (2017) MiR-124-3p attenuates hyperphosphorylation of tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells. Oncotarget 8:15, pages 24314-24326.
Crossref
Crossref
Sanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, Ines Baldeiras, Maria Bjerke, Kaj Blennow, Sebastiaan Engelborghs, Giovanni B. Frisoni, Tomasz Gabryelewicz, Samantha Galluzzi, Ron Handels, Milica G. Kramberger, Agnieszka Kulczyńska, Jose Luis Molinuevo, Barbara Mroczko, Agneta Nordberg, Catarina Resende Oliveira, Markus Otto, Juha O. Rinne, Uroš Rot, Esen Saka, Hilkka Soininen, Hanne Struyfs, Silvia Suardi, Pieter Jelle Visser, Bengt Winblad, Henrik Zetterberg & Gunhild Waldemar. (2016) Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia 13:3, pages 285-295.
Crossref
Crossref
Linda J.C. van Waalwijk van Doorn, Juan D. Gispert, H. Bea Kuiperij, Jurgen A.H.R. Claassen, Andrea Arighi, Inês Baldeiras, Kaj Blennow, Marco Bozzali, Miguel Castelo-Branco, Enrica Cavedo, Derya D. Emek-Savaş, Erden Eren, Paolo Eusebi, Lucia Farotti, Chiara Fenoglio, Juan Fortea Ormaechea, Yvonne Freund-Levi, Giovanni B. Frisoni, Daniela Galimberti, Sermin Genc, Viviana Greco, Harald Hampel, Sanna-Kaisa Herukka, Yawu Liu, Albert Lladó, Alberto Lleó, Flavio M. Nobili, Kader K. Oguz, Lucilla Parnetti, João Pereira, Agnese Picco, Maria Pikkarainen, Catarina Resende de Oliveira, Esen Saka, Nicola Salvadori, Raquel Sanchez-Valle, Isabel Santana, Elio Scarpini, Philip Scheltens, Hilkka Soininen, Roberto Tarducci, Charlotte Teunissen, Magda Tsolaki, Andrea Urbani, Eduard Vilaplana, Pieter Jelle Visser, Asa K. Wallin, Görsev Yener, José L. Molinuevo, Olga Meulenbroek & Marcel M. Verbeek. (2017) Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes. Journal of Alzheimer's Disease 56:2, pages 543-555.
Crossref
Crossref
亦刚 陈. (2017) Abnormally Phosphorylated Tau and Tauopathies. International Journal of Psychiatry and Neurology 06:02, pages 7-12.
Crossref
Crossref
Jieyun Sun, Xiong Zhang, Chen Wang, Zhipeng Teng & Yu Li. (2017) Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer’s Disease Mice. The American Journal of Chinese Medicine 45:08, pages 1667-1682.
Crossref
Crossref
Giulia M. Sancesario, Sofia Toniolo, Davide Chiasserini, Simona G. Di Santo, Josh Zegeer, Gaetano Bernardi, Massimo Musicco, Carlo Caltagirone, Lucilla Parnetti & Sergio Bernardini. (2016) The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Diagnosis: The Italian Selfie. Journal of Alzheimer's Disease 55:4, pages 1659-1666.
Crossref
Crossref
Ruth A. Wood, Kuven K. Moodley, Colin Lever, Ludovico Minati & Dennis Chan. (2016) Allocentric Spatial Memory Testing Predicts Conversion from Mild Cognitive Impairment to Dementia: An Initial Proof-of-Concept Study. Frontiers in Neurology 7.
Crossref
Crossref
Salvatore Mazzeo, Roberto Santangelo, Maria Paola Bernasconi, Giordano Cecchetti, Agnese Fiorino, Patrizia Pinto, Gabriella Passerini, Monica Falautano, Giancarlo Comi & Giuseppe Magnani. (2016) Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer’s Disease Dementia. Journal of Alzheimer's Disease 54:4, pages 1495-1508.
Crossref
Crossref
Judith Schuster & Susanne Aileen Funke. (2016) Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid. Journal of Alzheimer's Disease 53:1, pages 53-67.
Crossref
Crossref
Mahmoud Bukar Maina, Youssra Al-Hilaly & Louise Serpell. (2016) Nuclear Tau and Its Potential Role in Alzheimer’s Disease. Biomolecules 6:1, pages 9.
Crossref
Crossref
T.K. Khan. 2016. Biomarkers in Alzheimer's Disease. Biomarkers in Alzheimer's Disease
139
180
.
Lucette A Cysique, Timothy Hewitt, Juliana Croitoru-Lamoury, Kevin Taddei, Ralph N Martins, Constance SN Chew, Nicholas NWS Davies, Patricia Price & Bruce J Brew. (2015) APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals – a cross-sectional observational study. BMC Neurology 15:1.
Crossref
Crossref
Katherine Leaver & Kathleen L. Poston. (2015) Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review. Neuropsychology Review 25:4, pages 411-423.
Crossref
Crossref
Beibei Wu, Yan Wei, Yujing Wang, Tao Su, Lei Zhou, Ying Liu & Rongqiao He. (2015) Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice. Oncotarget 6:33, pages 34128-34142.
Crossref
Crossref
Keerthanaa Balasubramanian Shanthi, Sreeram Krishnan & P Rani. (2015) A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease. SAGE Open Medicine 3, pages 205031211559825.
Crossref
Crossref
Kenia Kelly Fiaux do Nascimento, Kelly P. Silva, Leandro F. Malloy-Diniz, Meryl A. Butters & Breno S. Diniz. (2015) Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis. Journal of Psychiatric Research 69, pages 35-41.
Crossref
Crossref
Jay Amin, Claire Paquet, Alex Baker, Ayodeji A. Asuni, Seth Love, Clive Holmes, Jacques Hugon, James A. R. Nicoll & Delphine Boche. (2015) Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β. Neuropathology and Applied Neurobiology 41:4, pages 445-457.
Crossref
Crossref
Vishal Jindal. (2014) Interconnection Between Brain and Retinal Neurodegenerations. Molecular Neurobiology 51:3, pages 885-892.
Crossref
Crossref
Javier G. Villamil-Ortiz & Gloria P. Cardona-Gomez. (2015) Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer’s disease animal models. Frontiers in Aging Neuroscience 7.
Crossref
Crossref
Maria Helena Madeira, António Francisco Ambrósio & Ana Raquel Santiago. (2015) Glia-Mediated Retinal Neuroinflammation as a Biomarker in Alzheimer's Disease. Ophthalmic Research 54:4, pages 204-211.
Crossref
Crossref
Kaj Blennow, Bruno Dubois, Anne M. Fagan, Piotr Lewczuk, Mony J. Leon & Harald Hampel. (2014) Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimer's & Dementia 11:1, pages 58-69.
Crossref
Crossref
Daniel Ferreira, Amado Rivero-Santana, Lilisbeth Perestelo-Pérez, Eric Westman, Lars-Olof Wahlund, Antonio SarrÃa & Pedro Serrano-Aguilar. (2014) Improving CSF Biomarkers’ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease by Considering Different Confounding Factors: A Meta-Analysis. Frontiers in Aging Neuroscience 6.
Crossref
Crossref
Daniel Ferreira, Lilisbeth Perestelo-Pérez, Eric Westman, Lars-Olof Wahlund, Antonio SarrÃa & Pedro Serrano-Aguilar. (2014) Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria. Frontiers in Aging Neuroscience 6.
Crossref
Crossref
Ana Solodkin, E. Elinor Chen, Gary W. Van Hoesen, Lennart Heimer, Ahmed Shereen, Frithjof Kruggel & James Mastrianni. (2013) In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease. Journal of Comparative Neurology 521:18, pages 4300-4317.
Crossref
Crossref
B. Dubois, S. Epelbaum, A. Santos, F. Di Stefano, A. Julian, A. Michon, M. Sarazin & H. Hampel. (2013) Alzheimer disease: From biomarkers to diagnosis. Revue Neurologique 169:10, pages 744-751.
Crossref
Crossref
Ramune Grambaite, Erik Hessen, Eirik Auning, Dag Aarsland, Per Selnes & Tormod Fladby. (2013) Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers. Dementia and Geriatric Cognitive Disorders Extra 3:1, pages 291-300.
Crossref
Crossref
Orestes V. Forlenza, Breno S. Diniz, Antonio L. Teixeira, Florindo Stella & Wagner Gattaz. (2013) Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease. Revista Brasileira de Psiquiatria 35:3, pages 284-294.
Crossref
Crossref
Jasmine Ramcharitar, Steffen Albrecht, Veronica M. Afonso, Vikas Kaushal, David A. Bennett & Andrea C. LeBlanc. (2013) Cerebrospinal Fluid Tau Cleaved by Caspase-6 Reflects Brain Levels and Cognition in Aging and Alzheimer Disease. Journal of Neuropathology & Experimental Neurology 72:9, pages 824-832.
Crossref
Crossref
Argonde C. Harten, Pieter Jelle Visser, Yolande A.L. Pijnenburg, Charlotte E. Teunissen, Marinus A. Blankenstein, Philip Scheltens & Wiesje M. Flier. (2012) Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints. Alzheimer's & Dementia 9:5, pages 481-487.
Crossref
Crossref
Kevin Mullane & Michael Williams. (2013) Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?. Biochemical Pharmacology 85:3, pages 289-305.
Crossref
Crossref
Carlos Fernández-Viadero, Eloy Rodríguez Rodríguez, Onofre Combarros Pascual & Dámaso Crespo Santiago. (2013) Genética y enfermedad de Alzheimer: población en riesgo. Revista Española de Geriatría y Gerontología 48:1, pages 39-44.
Crossref
Crossref
Andrea Chincarini, Paolo Bosco, Gianluca Gemme, Silvia Morbelli, Dario Arnaldi, Francesco Sensi, Ilaria Solano, Nicola Amoroso, Sabina Tangaro, Renata Longo, Sandro Squarcia & Flavio Nobili. (2012) Alzheimer’s disease markers from structural MRI and FDG-PET brain images. The European Physical Journal Plus 127:11.
Crossref
Crossref
I. Riba, C.I. Jarca, X. Mundet, J.L. Tovar, F. Orfila, C. Nafría, A. Raga, A. Girona, P. Fernández-Lara, X. Castañé, J. Álvarez Sabin, I. Fernández Cortiñas, O. Maisterra, J. Montaner & P. Delgado. (2012) Cognitive assessment protocol design in the ISSYS (Investigating Silent Strokes in hYpertensives: A magnetic resonance imaging Study). Journal of the Neurological Sciences 322:1-2, pages 79-81.
Crossref
Crossref
Valerie C. Cullen, Ross A. Fredenburg, Cindy Evans, Phyllis R. Conliffe & Michael E. Solomon. (2012) Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid. The AAPS Journal 14:3, pages 510-518.
Crossref
Crossref
Michael Williams & Joseph T. Coyle. 2012. Translational Neuroscience. Translational Neuroscience
129
148
.
J.A. Monge-Argilés, J. Sánchez-Payá, C. Muñoz-Ruiz, A. Pampliega-Pérez, M.J. Gómez-López, E. Rodríguez Borja, J. Montoya-Gutiérrez & C. Leiva-Santana. (2012) Patients with mild cognitive impairment and a reduced CSF Aβ1-42 protein progress rapidly to Alzheimer's disease. Neurología (English Edition) 27:1, pages 28-33.
Crossref
Crossref
J.A. Monge-Argilés, J. Sánchez-Payá, C. Muñoz-Ruiz, A. Pampliega-Pérez, M.J. Gómez-López, E. Rodríguez Borja, J. Montoya-Gutiérrez & C. Leiva-Santana. (2012) Pacientes con deterioro cognitivo leve y reducción de la proteína Aβ1-42 en LCR evolucionan rápidamente a enfermedad de Alzheimer. Neurología 27:1, pages 28-33.
Crossref
Crossref
Vanessa J. De-Paula, Marcia Radanovic, Breno S. Diniz & Orestes V. Forlenza. 2012. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
329
352
.
Breno Satler Diniz & Antonio Lucio Teixeira. (2011) Brain-Derived Neurotrophic Factor and Alzheimer’s Disease: Physiopathology and Beyond. NeuroMolecular Medicine 13:4, pages 217-222.
Crossref
Crossref
Luiz K. Ferreira, Breno S. Diniz, Orestes V. Forlenza, Geraldo F. Busatto & Marcus V. Zanetti. (2011) Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies. Neurobiology of Aging 32:10, pages 1733-1741.
Crossref
Crossref
Martijn C. de Wilde, Patrick J.G.H. Kamphuis, John W.C. Sijben & Phillip Scheltens. (2011) Utility of imaging for nutritional intervention studies in Alzheimer's disease. European Journal of Pharmacology 668, pages S59-S69.
Crossref
Crossref
Dorothy G. Flood, Gerard J. Marek & Michael Williams. (2011) Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine. Biochemical Pharmacology 81:12, pages 1422-1434.
Crossref
Crossref
Orestes V. Forlenza, Breno S. Diniz, Márcia Radanovic, Franklin S. Santos, Leda L. Talib & Wagner F. Gattaz. (2018) Disease-modifying properties of long-term lithium treatment for
amnestic mild cognitive impairment: randomised controlled
trial. British Journal of Psychiatry 198:5, pages 351-356.
Crossref
Crossref
Milton C Biagioni & James E Galvin. (2011) Using biomarkers to improve detection of Alzheimer’s disease. Neurodegenerative Disease Management 1:2, pages 127-139.
Crossref
Crossref
Valerio Leoni. (2011) The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease. cclm 49:3, pages 375-383.
Crossref
Crossref
L.M. Bekris, N.M. Galloway, S. Millard, D. Lockhart, G. Li, D.R. Galasko, M.R. Farlow, C.M. Clark, J.F. Quinn, J.A. Kaye, G.D. Schellenberg, J.B. Leverenz, P. Seubert, D.W. Tsuang, E.R. Peskind & C.E. Yu. (2011) Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiology of Aging 32:3, pages 556.e13-556.e23.
Crossref
Crossref
Orestes V. Forlenza, Carolina A. Torres, Leda L. Talib, Vanessa J. de Paula, Helena P.G. Joaquim, Breno S. Diniz & Wagner F. Gattaz. (2011) Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer’s disease. Journal of Psychiatric Research 45:2, pages 220-224.
Crossref
Crossref
David Prvulovic & Harald Hampel. (2011) Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Clinical Chemistry and Laboratory Medicine 49:3.
Crossref
Crossref
Jonathan H Williams, Gordon K Wilcock, Jeffrey Seeburger, Aimee Dallob, Omar Laterza, William Potter & A David Smith. (2011) Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study. Alzheimer's Research & Therapy 3:1, pages 5.
Crossref
Crossref
Denise C. Park & Gérard N. Bischof. 2011. Handbook of the Psychology of Aging. Handbook of the Psychology of Aging
109
119
.
Antonio Lucio Teixeira, Izabela Guimarães Barbosa, Breno Satler Diniz & Arthur Kummer. (2010) Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarkers in Medicine 4:6, pages 871-887.
Crossref
Crossref
Orestes V Forlenza, Breno S Diniz & Wagner F Gattaz. (2010) Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Medicine 8:1.
Crossref
Crossref
Larry G Brooks & David A Loewenstein. (2010) Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions. Alzheimer's Research & Therapy 2:5.
Crossref
Crossref
Orestes V. Forlenza, Breno S. Diniz, Leda L. Talib, Marcia Radanovic, Monica S. Yassuda, Elida B. Ojopi & Wagner F. Gattaz. (2010) Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria 32:3, pages 216-222.
Crossref
Crossref
FERNANDA SPEGGIORIN PEREIRA, MÔNICA SANCHES YASSUDA, ALEXANDRA MARTINI OLIVEIRA, BRENO SATLER DINIZ, MÁRCIA RADANOVIC, LEDA LEME TALIB, WAGNER FARID GATTAZ & ORESTES VICENTE FORLENZA. (2010) Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. Journal of the International Neuropsychological Society 16:2, pages 297-305.
Crossref
Crossref
Charlotte L. Allan, Claire E. Sexton, David Welchew & Klaus P. Ebmeier. (2010) Imaging and biomarkers for Alzheimer's disease. Maturitas 65:2, pages 138-142.
Crossref
Crossref
Orestes Vicente Forlenza, Breno Satler Diniz, Paula Villela Nunes, Claudia Maia Memória, Monica Sanches Yassuda & Wagner Farid Gattaz. (2009) Diagnostic transitions in mild cognitive impairment subtypes. International Psychogeriatrics 21:6, pages 1088-1095.
Crossref
Crossref
Karen M. Rodrigue, Kristen M. Kennedy & Denise C. Park. (2009) Beta-Amyloid Deposition and the Aging Brain. Neuropsychology Review 19:4, pages 436-450.
Crossref
Crossref
Rodolfo B. Ladeira, Breno S. Diniz, Paula V. Nunes & Orestes V. Forlenza. (2009) Combining Cognitive Screening Tests for the Evaluation of Mild Cognitive Impairment in the Elderly. Clinics 64:10, pages 967-973.
Crossref
Crossref
Karen Koopman, Nathalie Le Bastard, Jean-Jacques Martin, Guy Nagels, Peter P. De Deyn & Sebastiaan Engelborghs. (2009) Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P. Neurochemistry International 55:4, pages 214-218.
Crossref
Crossref
Breno Satler Diniz, Jony Arrais PintoJrJr, Maria Luiza Cavichioli Gonzaga, Fabiana Meira Guimarães, Wagner Farid Gattaz & Orestes Vicente Forlenza. (2009) To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease. European Archives of Psychiatry and Clinical Neuroscience 259:4, pages 248-256.
Crossref
Crossref
M. L. F. Balthazar, C. L. Yasuda, F. R. Pereira, T. Pedro, B. P. Damasceno & F. Cendes. (2009) Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer’s disease. European Journal of Neurology 16:4, pages 468-474.
Crossref
Crossref
K. Blennow, G. Meyer, O. Hansson, L. Minthon, A. Wallin, H. Zetterberg, P. Lewczuk, H. Vanderstichele, E. Vanmechelen, J. Kornhuber & J. Wiltfang. (2009) Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment. The Journal of Nutrition, Health and Aging 13:3, pages 205-208.
Crossref
Crossref
. (2008) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 24:1.
Crossref
Crossref
Breno Satler Diniz, Paula Villela Nunes, Monica S Yassuda, Fernanda S Pereira, Mariana K Flaks, Luciane F Viola, Marcia Radanovic, Izabella Dutra de Abreu, Danilo T Borelli, Wagner F Gattaz & Orestes Vicente Forlenza. (2008) Mild cognitive impairment: cognitive screening or neuropsychological assessment?. Revista Brasileira de Psiquiatria 30:4, pages 316-321.
Crossref
Crossref
Anja Schneider & Eckhard Mandelkow. (2008) Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics 5:3, pages 443-457.
Crossref
Crossref
Jiajia Fu, Yan Huang, Ting Bao, Jing Yang, Sihui Chen, Xueping Chen & Huifang Shang. (2022) Meta-Analysis and Systematic Review of Peripheral Platelet-Associated Biomarkers to Explore the Pathophysiology of Alzheimer's Disease. SSRN Electronic Journal.
Crossref
Crossref